Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Adiponectin  [Clear All Filters]
2019
Spracklen CN, Karaderi T, Yaghootkar H, et al. "Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology." Am J Hum Genet. 2019;105(1):15-28.
2014
Dearborn JL, Schneider ALC, Gottesman RF, et al. "Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study." Neurology. 2014;83(24):2211-8.
2013
Yaghootkar H, Lamina C, Scott RA, et al. "Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes." Diabetes. 2013;62(10):3589-98.
Raynor LA, Pankow JS, Duncan BB, et al. "Novel risk factors and the prediction of type 2 diabetes in the Atherosclerosis Risk in Communities (ARIC) study." Diabetes Care. 2013;36(1):70-6.
Dastani Z, Johnson T, Kronenberg F, Nelson CP, Assimes TL, März W. "The shared allelic architecture of adiponectin levels and coronary artery disease." Atherosclerosis. 2013;229(1):145-8.
2010
Zhu N, Pankow JS, Ballantyne CM, et al. "High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study." J Clin Endocrinol Metab. 2010;95(11):5097-104.
2006
Schmidt MI, Duncan BB, Vigo A, et al. "Leptin and incident type 2 diabetes: risk or protection?" Diabetologia. 2006;49(9):2086-96.
2004
Duncan BB, Schmidt M I, Pankow JS, et al. "Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study." Diabetes. 2004;53(9):2473-8.